Navigation Links
‘Aricept’ drug gives an Alzheimer’s patient reason to smle

Close on the heels of a petition from charities and campaign groups to extend the reach of Alzheimer’s drugs, the NHS drug regulator has disallowed// the use of the drug during the preliminary stages of the disease.

When John, aged 77, showed initial symptoms of Alzheimer’s, doctors had recommended the benefit of one of the controversial drugs, ‘Aricept’ in retarding the advancement of the disease. After 2 years of consuming the drug, which had improved John’s life remarkably, Doctors suggested that John participate in the clinical trial of a new drug that held promise for reversing the downslide in Alzheimer’s patients.

During the trial, the drug ‘Aricept’ was replaced by the new drug. John’s wife, Valerie, could visibly perceive the rapid decline in John’s condition with the new drug. Valerie perceivably distraught said,” In just a couple of weeks after coming off the drug, he absolutely fell to pieces. He had been able to do most things; make a cup of tea, dress himself. But he was totally dependent within the fortnight. He couldn't dress himself; he started to wander and to fall. He didn't even know where our bedroom was."

Presently the couple have withdrawn from the clinical trial of the new drug and reverted to the previous treatment with ‘Aricept.’ The couple vouch that this drug had done wonders to improve their quality of life.

The National Institute for health and Clinical Excellence reiterated, the drugs are not to be used for management of early stages of the disease.

Source-Medndia
SAV
'"/>




Page: 1

Related medicine news :

1. Microchip gives blind a chance of sight
2. Microchip gives blind a chance of sight
3. Combined scan gives exact cancer diagnosis
4. Tennis gives protection against heart disease lifelong
5. Camera gives hope for detection of breast cancer
6. Pancreas transplant gives hope to type 2 diabetes
7. FDA gives “black box warning” against three asthma drus
8. Trust in Doctor gives better cure
9. Wonder drug Dasatinib gives hopes to leukemia patients
10. 5 Year Old Paralyzed Victim Forgives 50 Year Old Man Who Shot Her
11. LA County gives Approval for Reform Plan for King-Drew Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2016)... ... May 02, 2016 , ... Zitter ... Specialty Pharmacy Patient Satisfaction Award that will recognize specialty pharmacies for their achievements ... Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout 2016. Results will ...
(Date:5/2/2016)... ... ... The 2016 World Ultimate & Guts Championship (WUGC) Mixed roster was announced in February and ... WUGC is being held in London, England this year from June 18-25. At the last ... gold in the women’s masters division, and a silver in the women’s division, so Mazur ...
(Date:5/2/2016)... ... ... Pregnancy Awareness Month offers a great time to get familiar with the latest ... to have a baby, it’s best to get started before age becomes an issue,” ... & Pregnancy Organizer, written for women who plan on becoming pregnant to learn about ...
(Date:5/2/2016)... ... 02, 2016 , ... A research team, including a director ... determined that the adjustability and adaptability of pediatric support surfaces – characteristics of ... which are now referred to as “pressure injuries” by the National Pressure Ulcer ...
(Date:5/2/2016)... ... , ... Atlantic Information Services, Inc. (AIS) is pleased to announce its upcoming ... Pharma Landscape .” CMS recently proposed a test of alternate payment models for Medicare ... care provided to beneficiaries. The webinar will review the details of this model, how ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016  Marking its ... accessible breast and ovarian cancer risk test, ... analyzing 30 genes that highly impact the most ... Available today, the Color Test analyzes hereditary cancer ... stomach, and uterine cancers. The Color Test is ...
(Date:4/28/2016)... , Net Sales of $1.90 billion represent ... prior year period, and an increase of 1.2% on an ... for the first quarter were $0.52 reported, a decrease of ... increase of 29.9% over the prior year period , ... for 2016 Zimmer Biomet Holdings, Inc. (NYSE and ...
(Date:4/28/2016)... FREMONT, Calif. , April 28, 2016 ... Enterprise Validation Lifecycle Management Solutions (VLMS) today ... products and services for sufferers of chronic ... management System to manage their corporate validation ... been seeking a software solution to manage ...
Breaking Medicine Technology: